Robert C. Bast Jr.

Add links
From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Simeon (talk | contribs) at 18:52, 28 December 2021 (Importing Wikidata short description: "American physician-scientist" (Shortdesc helper)). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Robert C. Bast Jr.
Born(1943-12-08)December 8, 1943
Alma mater
Scientific career
InstitutionsUniversity of Texas MD Anderson Cancer Center
Website

Robert Clinton Bast Jr., (born December 8, 1943) is an American physician-scientist who is currently Vice President for Translational Research at the University of Texas M.D. Anderson Cancer Center.[1] Bast is best known for the discovery of CA125, a serum biomarker for ovarian cancer that has contributed to the care of ovarian cancer patients worldwide.[2] His research spans early detection, enhancing chemotherapy and understanding regulation of dormancy and the role of autophagy in breast and ovarian cancer.

References[edit]

  1. ^ "Robert C. Bast". MD Anderson Cancer Center. Retrieved 2019-05-20.
  2. ^ "Robert C. Bast, Jr., M.D." NFCR. Retrieved 2019-05-20.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Robert_C._Bast_Jr.&oldid=1062482720"